Clinical trial
Hormone Therapy in Treating Patients With Prostate Cancer
NCT00003323 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003323 |
|---|---|
| Title | Hormone Therapy in Treating Patients With Prostate Cancer |
| Official title | A Phase II Trial of Potency-Sparing Hormonal Therapy in Patients With Elevated Serum PSA After Radiation Therapy or Radical Prostatectomy for Prostate Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Sexual Dysfunction and Infertility |
| Intervention type | Drug, Other |
| Interventions | finasteride, flutamide, quality-of-life assessment |
| Enrollment | 101 |
| Start date | May 1, 1998 |
| Primary completion | May 1, 2002 |
| Completion | Mar 1, 2010 |
| First posted | Aug 13, 2003 |
| Last update posted | Jul 4, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: